公开(公告)号：WO2021232396A1

公开(公告)日：2021-11-25

申请号：PCT/CN2020/091722

申请日：2020-05-22

Applicant: INTEL CORPORATION ,  LI, Yufu,Kevin ,  CHAI, Zhenfu ,  ZHU, Lei ,  HE, Junjie ,  LIU, Shijie ,  XU, Tao

Inventor： LI, Yufu,Kevin ,  CHAI, Zhenfu ,  ZHU, Lei ,  HE, Junjie ,  LIU, Shijie ,  XU, Tao

IPC: G06F9/445

Abstract: Systems, apparatuses and methods may provide for technology that initializes a host-managed device memory (HDM) as a temporary proxy for a system memory, wherein the HDM is associated with an accelerator. The technology also creates a shadow copy of boot firmware code in the HDM and executes one or more boot instructions in the shadow copy of the boot firmware code. In one example, the one or more boot instructions are to be one or more of executed before an initialization of the system memory or executed in parallel with the initialization of the system memory.

公开(公告)号：WO2010068654A1

公开(公告)日：2010-06-17

申请号：PCT/US2009/067289

申请日：2009-12-09

Applicant: ETHICON, INC. ,  LI, Yufu ,  WOHLHERT, Stephen ,  YANG, Chunlin

Inventor： LI, Yufu ,  WOHLHERT, Stephen ,  YANG, Chunlin

IPC: A61K9/14 ,  A61K9/20 ,  A61K31/375

CPC classification number: A61K31/375 ,  A61K9/7007 ,  A61L31/16

Abstract: A novel method of preparing a controlled release composition is disclosed. Specifically, the present invention relates to a method of preparing controlled release compositions of ascorbic acid phosphate and absorbable polymers. Also disclosed is a novel controlled release composition of ascorbic acid phosphate made by the method of the present invention.

Abstract translation: 公开了制备控释组合物的新方法。 具体地说，本发明涉及一种制备抗坏血酸磷酸盐和可吸收聚合物的控释组合物的方法。 还公开了通过本发明的方法制备的抗坏血酸磷酸盐的新型控释组合物。

公开(公告)号：WO2010043710A2

公开(公告)日：2010-04-22

申请号：PCT/EP2009/063588

申请日：2009-10-16

Applicant: DEPUY INTERNATIONAL LIMITED ,  LI, Yufu ,  SCHACHTER, Deborah ,  SHISSIAS, Raymond, S ,  WECHSLER, Sandra

Inventor： LI, Yufu ,  SCHACHTER, Deborah ,  SHISSIAS, Raymond, S ,  WECHSLER, Sandra

IPC: A61L31/10 ,  A61L31/16

CPC classification number: A61L31/16 ,  A61L31/10 ,  A61L2300/406 ,  A61L2300/608 ,  A61L2420/08 ,  C08L67/04

Abstract: An implantable medical device, which comprises a device substrate, a coating on the substrate which includes a drug which is highly soluble in water, and a protective layer which overlies the coating. The protective layer comprises a polymer selected from the group consisting of polylactic acid, polyglycolic acid and a lactic acid/glycolic acid copolymer having a weight average molecular weight of not more than 40,000.

Abstract translation: 一种可植入医疗装置，其包括装置基板，基底上的涂层，其包括高度溶于水的药物，以及覆盖在所述涂层上的保护层。 保护层包含选自聚乳酸，聚乙醇酸和重均分子量不大于40,000的乳酸/乙醇酸共聚物的聚合物。

公开(公告)号：WO2015042864A1

公开(公告)日：2015-04-02

申请号：PCT/CN2013/084441

申请日：2013-09-27

Applicant: INTEL CORPORATION ,  ZHOU, Xiaohu ,  LI, Yufu

Inventor： ZHOU, Xiaohu ,  LI, Yufu

IPC: G06F1/32

CPC classification number: G06F1/329 ,  G06F1/189 ,  G06F1/26 ,  G06F1/3203 ,  G06F1/3206 ,  G06F1/325 ,  G06F9/4401 ,  H05K7/1498 ,  Y02D10/24

Abstract: Methods and apparatus relating to optimizing boot-time peak power consumption for server and/or rack systems are described. In an embodiment, a module execution sequence for a computing device is determined to indicate a sequence of module execution during a boot process of the computing device. The module execution sequence is determined based at least partially on power consumption data and timeline data for each module of the computing device during the boot process of the computing device. Other embodiments are also claimed and described.

Abstract translation: 描述了与服务器和/或机架系统的引导时峰值功耗优化有关的方法和装置。 在一个实施例中，用于计算设备的模块执行顺序被确定为在计算设备的引导过程期间指示模块执行的顺序。 至少部分地基于在计算设备的引导过程期间计算设备的每个模块的功耗数据和时间线数据来确定模块执行序列。 还要求保护和描述其它实施例。

公开(公告)号：WO2010111502A3

公开(公告)日：2010-09-30

申请号：PCT/US2010/028686

申请日：2010-03-25

Applicant: ETHICON, INC. ,  YANG, Chunlin ,  SUN, Ying ,  CICHOCKI, Frank, R. ,  BAR, Saumen, N. ,  HAUSCHILD, James, E. ,  HERZBERG, Uri ,  LI, Yufu ,  MING, Xiantian ,  KONG, Wei

Inventor： YANG, Chunlin ,  SUN, Ying ,  CICHOCKI, Frank, R. ,  BAR, Saumen, N. ,  HAUSCHILD, James, E. ,  HERZBERG, Uri ,  LI, Yufu ,  MING, Xiantian ,  KONG, Wei

IPC: A61L15/18 ,  A61L15/42 ,  A61L26/00 ,  A61L27/30 ,  A61L27/50 ,  A61L29/10 ,  A61L29/14 ,  A61L31/08 ,  A61L31/14 ,  A61K6/00

Abstract: Implantable medical devices having galvanic particulates are disclosed. The particulates may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The devices may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, and tissue regeneration promoting.

公开(公告)号：WO2009070912A1

公开(公告)日：2009-06-11

申请号：PCT/CN2007/003367

申请日：2007-11-29

Applicant: INTEL CORPORATION ,  CAI, Xiaohua ,  LI, Yufu

Inventor： CAI, Xiaohua ,  LI, Yufu

IPC: H04L12/56

CPC classification number: H04L45/02

Abstract: Methods and apparatus to improve modification of system routing information in link based systems are described. In one embodiment, entries in a first table (storing data corresponding to routing paths between a plurality of components prior to a hot-plug event) and a second table (storing data corresponding to routing paths between the plurality of components after a hot-plug event) may be compared to determine which corresponding routing registers are to be modified in response to the hot-plug event. Other embodiments are also disclosed.

Abstract translation: 描述了改进基于链路的系统中系统路由信息修改的方法和装置。 在一个实施例中，第一表中的条目（存储对应于热插拔事件之前的多个部件之间的路由路径的数据）和第二表（存储对应于热插拔之后的多个部件之间的路由路径的数据） 事件），以确定响应于热插拔事件来修改哪些对应的路由寄存器。 还公开了其他实施例。

公开(公告)号：WO2021196065A1

公开(公告)日：2021-10-07

申请号：PCT/CN2020/082676

申请日：2020-04-01

Applicant: INTEL CORPORATION ,  LI, Yufu,Kevin ,  CHAI, Zhenfu ,  LIU, Shijie ,  DENG, Zhiguo ,  WANG, Fei

Inventor： LI, Yufu,Kevin ,  CHAI, Zhenfu ,  LIU, Shijie ,  DENG, Zhiguo ,  WANG, Fei

IPC: G06F9/48

Abstract: Systems, apparatuses and methods may provide for technology that detects, by a remote processor coupled to a remote socket, a transition request from a system processor coupled to a system socket, wherein the system socket has an indirect link with the remote socket. The technology may also automatically conduct an operational speed transition at the remote socket in response to the transition request, wherein the operational speed transition at the remote socket is to occur in parallel with a plurality of operational speed transitions at a corresponding plurality of peer sockets.

公开(公告)号：WO2012078815A1

公开(公告)日：2012-06-14

申请号：PCT/US2011/063840

申请日：2011-12-07

Applicant: ADVANCED TECHNOLOGIES AND REGENERATIVE MEDICINE, LLC ,  SCHACHTER, Deborah, M. ,  ZHANG, Qian ,  VAN REMOORTERE, Peter ,  LI, Yufu

Inventor： SCHACHTER, Deborah, M. ,  ZHANG, Qian ,  VAN REMOORTERE, Peter ,  LI, Yufu

IPC: A61K9/16 ,  A61K9/00 ,  A61K47/48

CPC classification number: A61K9/0024 ,  A61K9/1647 ,  A61K47/6951 ,  B82Y5/00 ,  Y02A50/411

Abstract: We have disclosed an implantable sustained release composition comprising, a biocompatible, biodegradable polymer, a cyclodextrin inclusion complex of a poorly water soluble pharmaceutical agent present, and a plasticizer, where the polymer is the minority phase of the formulation. Furthermore, we disclose an implantable sustained release composition that provides a detectable plasma level of an otherwise poorly soluble drug for at least 28 days.

Abstract translation: 我们已经公开了一种植入式缓释组合物，其包含生物相容性生物可降解聚合物，存在的水溶性差的药物的环糊精包合物和增塑剂，其中所述聚合物是制剂的少数阶段。 此外，我们公开了一种植入式持续释放组合物，其提供可检测的血浆水平的其他难溶性药物至少28天。

公开(公告)号：WO2010111502A2

公开(公告)日：2010-09-30

申请号：PCT/US2010028686

申请日：2010-03-25

Applicant: ETHICON INC ,  YANG CHUNLIN ,  SUN YING ,  CICHOCKI FRANK R ,  BAR SAUMEN N ,  HAUSCHILD JAMES E ,  HERZBERG URI ,  LI YUFU ,  MING XIANTIAN ,  KONG WEI

Inventor： YANG CHUNLIN ,  SUN YING ,  CICHOCKI FRANK R ,  BAR SAUMEN N ,  HAUSCHILD JAMES E ,  HERZBERG URI ,  LI YUFU ,  MING XIANTIAN ,  KONG WEI

IPC: A61L15/18 ,  A61K6/00 ,  A61L15/42 ,  A61L26/00 ,  A61L27/30 ,  A61L27/50 ,  A61L29/10 ,  A61L29/14 ,  A61L31/08 ,  A61L31/14

CPC classification number: A61L27/306 ,  A61L27/52 ,  A61L27/54 ,  A61L29/106 ,  A61L29/14 ,  A61L29/16 ,  A61L31/088 ,  A61L31/145 ,  A61L31/16 ,  A61L2300/102 ,  A61L2300/104 ,  A61L2300/404 ,  A61L2300/41 ,  A61L2300/45 ,  A61L2300/606 ,  A61L2300/622 ,  A61L2420/04 ,  Y10T428/256

Abstract: Implantable medical devices having galvanic particulates are disclosed. The particulates may be coated onto at least part of a surface of the medical device. In addition, the galvanic particulates may be contained in the material used to manufacture the antimicrobial medical devices, or may be embedded into the surface of the medical devices. The present invention also provides novel coating methods and processing methods. The devices may have advantageous characteristics and effects including anti-microbial, anti-inflammatory, and tissue regeneration promoting.

Abstract translation: 公开了具有电偶颗粒的可植入医疗装置。 颗粒可以涂覆在医疗装置的表面的至少一部分上。 此外，电化学颗粒可以包含在用于制造抗微生物医疗装置的材料中，或者可以嵌入医疗装置的表面中。 本发明还提供了新的涂布方法和加工方法。 该装置可具有促进抗微生物，消炎和组织再生的有利特征和作用。

公开(公告)号：WO2009073680A1

公开(公告)日：2009-06-11

申请号：PCT/US2008/085309

申请日：2008-12-03

Applicant: ETHICON, INC. ,  ZHOU, Yue ,  COOPER, Kevin ,  LI, Yufu ,  LI, Zhigang

Inventor： ZHOU, Yue ,  COOPER, Kevin ,  LI, Yufu ,  LI, Zhigang

IPC: C08K9/00 ,  C08L67/04

CPC classification number: C08K9/08 ,  C08L23/08 ,  C08L67/02 ,  C08L67/04 ,  C08L69/00 ,  C08L2666/04

Abstract: A composite having a poly(ethylene-co-acrylic acid) coupling agent, a filler, and a biocompatible, biodegradable polymer matrix is disclosed. The composites described herein are useful for biomedical applications such as, tissue engineering, drug delivery, and implantable medical devices.

Abstract translation: 公开了具有聚（乙烯 - 共 - 丙烯酸）偶联剂，填料和生物相容的可生物降解的聚合物基质的复合材料。 本文所述的复合材料可用于生物医学应用，例如组织工程，药物递送和可植入医疗装置。